PL3094345T3 - Immunoterapia oparta na liposomach - Google Patents
Immunoterapia oparta na liposomachInfo
- Publication number
- PL3094345T3 PL3094345T3 PL15700478T PL15700478T PL3094345T3 PL 3094345 T3 PL3094345 T3 PL 3094345T3 PL 15700478 T PL15700478 T PL 15700478T PL 15700478 T PL15700478 T PL 15700478T PL 3094345 T3 PL3094345 T3 PL 3094345T3
- Authority
- PL
- Poland
- Prior art keywords
- liposome
- based immunotherapy
- immunotherapy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/577—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 tolerising response
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14151629 | 2014-01-17 | ||
| EP15700478.9A EP3094345B1 (en) | 2014-01-17 | 2015-01-16 | Liposome-based immunotherapy |
| PCT/EP2015/050747 WO2015107140A1 (en) | 2014-01-17 | 2015-01-16 | Liposome-based immunotherapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3094345T3 true PL3094345T3 (pl) | 2018-11-30 |
Family
ID=49949574
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15700478T PL3094345T3 (pl) | 2014-01-17 | 2015-01-16 | Immunoterapia oparta na liposomach |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20160338953A1 (pl) |
| EP (1) | EP3094345B1 (pl) |
| JP (2) | JP6546195B2 (pl) |
| CN (1) | CN106061502B (pl) |
| AU (1) | AU2015206016B2 (pl) |
| BR (1) | BR112016016356B1 (pl) |
| CA (1) | CA2939435C (pl) |
| ES (1) | ES2672247T3 (pl) |
| MX (1) | MX2016009217A (pl) |
| PL (1) | PL3094345T3 (pl) |
| TR (1) | TR201807778T4 (pl) |
| WO (1) | WO2015107140A1 (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3094345B1 (en) * | 2014-01-17 | 2018-03-14 | Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol | Liposome-based immunotherapy |
| EP2918262B1 (en) * | 2014-03-10 | 2023-08-09 | PLS-Design GmbH | Induction of antigen-specific tolerance by peripheral phagocytosis |
| AU2017394032B8 (en) | 2017-01-21 | 2020-10-22 | Guangzhou Hanfang Pharmaceutical Co., Ltd. | Use of paeoniflorin-6'-o-benzenesulfonate in treatment of sjögren's syndrome |
| EP3586300A4 (en) * | 2017-02-24 | 2020-12-09 | Ebner-Todd, Rene | KITCHEN APPLIANCE AND NUTRITION MANAGEMENT |
| WO2021102433A1 (en) * | 2019-11-22 | 2021-05-27 | The Research Foundation For The State University Of New York | Compositions and methods for use in type 1 diabetes |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5542935A (en) * | 1989-12-22 | 1996-08-06 | Imarx Pharmaceutical Corp. | Therapeutic delivery systems related applications |
| ATE395904T1 (de) * | 1996-09-13 | 2008-06-15 | Lipoxen Technologies Ltd | Liposome |
| CA2319928A1 (en) * | 2000-09-18 | 2002-03-18 | Vasogen Ireland Limited | Apoptosis-mimicking synthetic entities and use thereof in medical treatments |
| EP1547581A1 (en) * | 2003-12-23 | 2005-06-29 | Vectron Therapeutics AG | Liposomal vaccine for the treatment of human hematological malignancies |
| CA2569590C (en) * | 2004-06-11 | 2014-04-01 | Riken | Drug having regulatory cell ligand contained in liposome |
| CN101588813A (zh) * | 2005-04-12 | 2009-11-25 | 杜克大学 | 诱导人类免疫缺陷病毒的中和抗体的方法 |
| EP1909758A1 (en) * | 2005-08-02 | 2008-04-16 | I.D.M. Immuno-Designed Molecules | Process for the preparation of liposomal formulations |
| US10736848B2 (en) * | 2007-10-12 | 2020-08-11 | Massachusetts Institute Of Technology | Vaccine nanotechnology |
| EP2245059B1 (en) * | 2008-02-14 | 2017-09-20 | Life Sciences Research Partners VZW | Cd4+ t-cells with cytolytic properties |
| CN101502649B (zh) * | 2008-06-23 | 2011-11-30 | 深圳职业技术学院 | 一种脂质体流感疫苗 |
| US20120164189A1 (en) * | 2009-07-07 | 2012-06-28 | Balu-Iyer Sathy V | Lipidic Compositions for Induction of Immune Tolerance |
| EP2672958A1 (en) * | 2011-02-08 | 2013-12-18 | Halozyme, Inc. | Composition and lipid formulation of a hyaluronan-degrading enzyme and the use thereof for treatment of benign prostatic hyperplasia |
| JP6422773B2 (ja) * | 2011-04-29 | 2018-11-14 | セレクタ バイオサイエンシーズ インコーポレーテッドＳｅｌｅｃｔａ Ｂｉｏｓｃｉｅｎｃｅｓ，Ｉｎｃ． | 細胞傷害性ｔリンパ球応答を低下させる寛容原性合成ナノキャリア |
| US20150150996A1 (en) * | 2012-06-06 | 2015-06-04 | Northwestern University | Compositions and methods for antigen-specific tolerance |
| EP3094345B1 (en) * | 2014-01-17 | 2018-03-14 | Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol | Liposome-based immunotherapy |
-
2015
- 2015-01-16 EP EP15700478.9A patent/EP3094345B1/en active Active
- 2015-01-16 JP JP2016564400A patent/JP6546195B2/ja active Active
- 2015-01-16 CA CA2939435A patent/CA2939435C/en active Active
- 2015-01-16 TR TR2018/07778T patent/TR201807778T4/tr unknown
- 2015-01-16 ES ES15700478.9T patent/ES2672247T3/es active Active
- 2015-01-16 AU AU2015206016A patent/AU2015206016B2/en active Active
- 2015-01-16 CN CN201580007978.3A patent/CN106061502B/zh active Active
- 2015-01-16 WO PCT/EP2015/050747 patent/WO2015107140A1/en active Application Filing
- 2015-01-16 US US15/111,466 patent/US20160338953A1/en active Pending
- 2015-01-16 BR BR112016016356-7A patent/BR112016016356B1/pt active IP Right Grant
- 2015-01-16 PL PL15700478T patent/PL3094345T3/pl unknown
- 2015-01-16 MX MX2016009217A patent/MX2016009217A/es active IP Right Grant
-
2019
- 2019-06-20 JP JP2019114294A patent/JP2019196363A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2015206016A1 (en) | 2016-08-25 |
| BR112016016356B1 (pt) | 2023-12-26 |
| CN106061502A (zh) | 2016-10-26 |
| EP3094345B1 (en) | 2018-03-14 |
| CA2939435A1 (en) | 2015-07-23 |
| JP2017507171A (ja) | 2017-03-16 |
| CA2939435C (en) | 2023-09-19 |
| BR112016016356A2 (pt) | 2017-10-03 |
| AU2015206016B2 (en) | 2020-07-23 |
| JP2019196363A (ja) | 2019-11-14 |
| US20160338953A1 (en) | 2016-11-24 |
| MX2016009217A (es) | 2017-05-12 |
| WO2015107140A1 (en) | 2015-07-23 |
| TR201807778T4 (tr) | 2018-06-21 |
| JP6546195B2 (ja) | 2019-07-17 |
| EP3094345A1 (en) | 2016-11-23 |
| ES2672247T3 (es) | 2018-06-13 |
| CN106061502B (zh) | 2021-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202005298B (en) | Combination tumor immunotherapy | |
| GB201517022D0 (en) | No details | |
| GB201410907D0 (en) | No details | |
| GB201519531D0 (en) | No details | |
| GB201517404D0 (en) | No details | |
| SG11201606736YA (en) | Compound controls | |
| EP3215182A4 (en) | Combination immunotherapy | |
| GB201418217D0 (en) | No details | |
| PT3107573T (pt) | Imunoterapia com il-12 visada ao cancro | |
| GB201418216D0 (en) | No details | |
| GB201412290D0 (en) | Novel use | |
| GB201517412D0 (en) | No details | |
| SG11201700281SA (en) | Galectin immunotherapy | |
| GB201516796D0 (en) | No details | |
| GB201517574D0 (en) | No details | |
| ZA201803964B (en) | Tiled retrofeflector with mutli-stage dicing | |
| PL3094345T3 (pl) | Immunoterapia oparta na liposomach | |
| GB2541830B (en) | Positioning Unit | |
| GB201517605D0 (en) | No details | |
| PL2902575T3 (pl) | System okuciowy | |
| GB201417497D0 (en) | Novel use | |
| GB201410910D0 (en) | No details | |
| GB201517502D0 (en) | Positioning means | |
| GB2522661B (en) | Context configuration | |
| GB201417499D0 (en) | Novel use |